FTLD-ALS of TDP-43 type and SCA2 in a family with a full ataxin-2 polyglutamine expansion

Acta Neuropathologica

Volumn 128, Issue 4, 2014, Pages 597-604

  Bäumer, Dirk ^a,b   East, Simon Z ^a   Tseu, Bing ^a   Zeman, Adam ^c   Hilton, David ^d   Talbot, Kevin ^b   Ansorge, Olaf ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

^d DERRIFORD HOSPITAL   (United Kingdom)

Author keywords

Amyotrophic lateral sclerosis; Ataxin 2; Frontotemporal lobar degeneration; SCA2; TDP 43

Indexed keywords

DNA BINDING PROTEIN; NERVE PROTEIN; PROTEIN TDP-43; SCA2 PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; CASE REPORT; COMPLICATION; FAMILY HEALTH; GENETICS; HUMAN; MALE; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; SPINOCEREBELLAR DEGENERATION; TRINUCLEOTIDE REPEAT; VERY ELDERLY;

AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; FAMILY HEALTH; HUMANS; MALE; NERVE TISSUE PROTEINS; SPINOCEREBELLAR ATAXIAS; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 84897366996     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-014-1277-z     Document Type: Article

References (55)

1. Abe K, Ikeda Y, Kurata T, Ohta Y, Manabe Y, Okamoto M, Takamatsu K, Ohta T, Takao Y, Shiro Y, Shoji M, Kamiya T, Kobayashi H, Koizumi A (2012) Cognitive and affective impairments of a novel SCA/MND crossroad mutation Asidan. Eur J Neurol 19(8):1070–1078. doi:10.1111/j.1468-1331.2012.03669.x
2. Almeida-Silva UC, Hallak JE, Junior WM, Osorio Fde L (2013) Association between spinocerebellar ataxias caused by glutamine expansion and psychiatric and neuropsychological signals—a literature review. Am J Neurodegener Dis 2(2):57–69
3. Burk K, Globas C, Bosch S, Graber S, Abele M, Brice A, Dichgans J, Daum I, Klockgether T (1999) Cognitive deficits in spinocerebellar ataxia 2. Brain 122(Pt 4):769–777
4. Burk K, Globas C, Bosch S, Klockgether T, Zuhlke C, Daum I, Dichgans J (2003) Cognitive deficits in spinocerebellar ataxia type 1, 2, and 3. J Neurol 250(2):207–211. doi:10.1007/s00415-003-0976-5
5. Cancel G, Stevanin G, Durr A, Chneiweiss H, Penet C, Pothin Y, Agid Y, Brice A (1995) SCA2 is not a major locus for ADCA type I in French families. Am J Med Genet 60(5):382–385. doi:10.1002/ajmg.1320600507
6. Chong SS, McCall AE, Cota J, Subramony SH, Orr HT, Hughes MR, Zoghbi HY (1995) Gametic and somatic tissue-specific heterogeneity of the expanded SCA1 CAG repeat in spinocerebellar ataxia type 1. Nat Genet 10(3):344–350. doi:10.1038/ng0795-344
7. Corrado L, Mazzini L, Oggioni GD, Luciano B, Godi M, Brusco A, D’Alfonso S (2011) ATXN-2 CAG repeat expansions are interrupted in ALS patients. Hum Genet 130(4):575–580. doi:10.1007/s00439-011-1000-2
8. Daoud H, Belzil V, Martins S, Sabbagh M, Provencher P, Lacomblez L, Meininger V, Camu W, Dupre N, Dion PA, Rouleau GA (2011) Association of long ATXN2 CAG repeat sizes with increased risk of amyotrophic lateral sclerosis. Arch Neurol 68(6):739. doi:10.1001/archneurol.2011.111
9. Durr A, Smadja D, Cancel G, Lezin A, Stevanin G, Mikol J, Bellance R, Buisson GG, Chneiweiss H, Dellanave J et al (1995) Autosomal dominant cerebellar ataxia type I in Martinique (French West Indies). Clinical and neuropathological analysis of 53 patients from three unrelated SCA2 families. Brain 118(Pt 6):1573–1581
10. Elden AC, Kim HJ, Hart MP, Chen-Plotkin AS, Johnson BS, Fang X, Armakola M, Geser F, Greene R, Lu MM, Padmanabhan A, Clay-Falcone D, McCluskey L, Elman L, Juhr D, Gruber PJ, Rub U, Auburger G, Trojanowski JQ, Lee VM, Van Deerlin VM, Bonini NM, Gitler AD (2010) Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature 466(7310):1069–1075. doi:10.1038/nature09320
11. Estrada R, Galarraga J, Orozco G, Nodarse A, Auburger G (1999) Spinocerebellar ataxia 2 (SCA2): morphometric analyses in 11 autopsies. Acta Neuropathol 97(3):306–310
12. Flot J-F, Tillier A, Samadi S, Tillier S (2006) Phase determination from direct sequencing of length-variable DNA regions. Mol Ecol Notes 6(3):627–630. doi:10.1111/j.1471-8286.2006.01355.x
13. Furtado S, Payami H, Lockhart PJ, Hanson M, Nutt JG, Singleton AA, Singleton A, Bower J, Utti RJ, Bird TD, de la Fuente-Fernandez R, Tsuboi Y, Klimek ML, Suchowersky O, Hardy J, Calne DB, Wszolek ZK, Farrer M, Gwinn-Hardy K, Stoessl AJ (2004) Profile of families with Parkinsonism-predominant spinocerebellar ataxia type 2 (SCA2). Mov Disord 19(6):622–629. doi:10.1002/mds.20074
14. Gambardella A, Annesi G, Bono F, Spadafora P, Valentino P, Pasqua AA, Mazzei R, Montesanti R, Conforti FL, Oliveri RL, Zappia M, Aguglia U, Quattrone A (1998) CAG repeat length and clinical features in three Italian families with spinocerebellar ataxia type 2 (SCA2): early impairment of Wisconsin card sorting test and saccade velocity. J Neurol 245(10):647–652
15. Geschwind DH, Perlman S, Figueroa CP, Treiman LJ, Pulst SM (1997) The prevalence and wide clinical spectrum of the spinocerebellar ataxia type 2 trinucleotide repeat in patients with autosomal dominant cerebellar ataxia. Am J Hum Genet 60(4):842–850
16. Gierga K, Burk K, Bauer M, Orozco Diaz G, Auburger G, Schultz C, Vuksic M, Schols L, de Vos RA, Braak H, Deller T, Rub U (2005) Involvement of the cranial nerves and their nuclei in spinocerebellar ataxia type 2 (SCA2). Acta Neuropathol 109(6):617–631. doi:10.1007/s00401-005-1014-8
17. Gispert S, Kurz A, Waibel S, Bauer P, Liepelt I, Geisen C, Gitler AD, Becker T, Weber M, Berg D, Andersen PM, Kruger R, Riess O, Ludolph AC, Auburger G (2012) The modulation of amyotrophic lateral sclerosis risk by ataxin-2 intermediate polyglutamine expansions is a specific effect. Neurobiol Dis 45(1):356–361. doi:10.1016/j.nbd.2011.08.021
18. Giunti P, Sabbadini G, Sweeney MG, Davis MB, Veneziano L, Mantuano E, Federico A, Plasmati R, Frontali M, Wood NW (1998) The role of the SCA2 trinucleotide repeat expansion in 89 autosomal dominant cerebellar ataxia families. Frequency, clinical and genetic correlates. Brain 121(Pt 3):459–467
19. Hart MP, Brettschneider J, Lee VM, Trojanowski JQ, Gitler AD (2012) Distinct TDP-43 pathology in ALS patients with ataxin 2 intermediate-length polyQ expansions. Acta Neuropathol 124(2):221–230. doi:10.1007/s00401-012-0985-5
20. Hayes S, Turecki G, Brisebois K, Lopes-Cendes I, Gaspar C, Riess O, Ranum LP, Pulst SM, Rouleau GA (2000) CAG repeat length in RAI1 is associated with age at onset variability in spinocerebellar ataxia type 2 (SCA2). Hum Mol Genet 9(12):1753–1758
21. Ikeda Y, Ohta Y, Kobayashi H, Okamoto M, Takamatsu K, Ota T, Manabe Y, Okamoto K, Koizumi A, Abe K (2012) Clinical features of SCA36: a novel spinocerebellar ataxia with motor neuron involvement (Asidan). Neurology 79(4):333–341. doi:10.1212/WNL.0b013e318260436f
22. Imbert G, Saudou F, Yvert G, Devys D, Trottier Y, Garnier JM, Weber C, Mandel JL, Cancel G, Abbas N, Durr A, Didierjean O, Stevanin G, Agid Y, Brice A (1996) Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats. Nat Genet 14(3):285–291. doi:10.1038/ng1196-285
23. Infante J, Berciano J, Volpini V, Corral J, Polo JM, Pascual J, Combarros O (2004) Spinocerebellar ataxia type 2 with levodopa-responsive Parkinsonism culminating in motor neuron disease. Mov Disord 19(7):848–852. doi:10.1002/mds.20090
24. Kim JM, Hong S, Kim GP, Choi YJ, Kim YK, Park SS, Kim SE, Jeon BS (2007) Importance of low-range CAG expansion and CAA interruption in SCA2 Parkinsonism. Arch Neurol 64(10):1510–1518. doi:10.1001/archneur.64.10.1510
25. Koyano S, Uchihara T, Fujigasaki H, Nakamura A, Yagishita S, Iwabuchi K (1999) Neuronal intranuclear inclusions in spinocerebellar ataxia type 2: triple-labeling immunofluorescent study. Neurosci Lett 273(2):117
26. Laffita-Mesa JM, Bauer PO, Kouri V, Pena Serrano L, Roskams J, Almaguer Gotay D, Montes Brown JC, Martinez Rodriguez PA, Gonzalez-Zaldivar Y, Almaguer Mederos L, Cuello-Almarales D, Aguiar Santiago J (2012) Epigenetics DNA methylation in the core ataxin-2 gene promoter: novel physiological and pathological implications. Hum Genet 131(4):625. doi:10.1007/s00439-011-1101-y
27. Le Pira F, Zappala G, Saponara R, Domina E, Restivo D, Reggio E, Nicoletti A, Giuffrida S (2002) Cognitive findings in spinocerebellar ataxia type 2: relationship to genetic and clinical variables. J Neurol Sci 201(1–2):53–57
28. Lee T, Li YR, Ingre C, Weber M, Grehl T, Gredal O, de Carvalho M, Meyer T, Tysnes OB, Auburger G, Gispert S, Bonini NM, Andersen PM, Gitler AD (2011) Ataxin-2 intermediate-length polyglutamine expansions in European ALS patients. Hum Mol Genet 20(9):1697–1700. doi:10.1093/hmg/ddr045
29. Liu X, Lu M, Tang L, Zhang N, Chui D, Fan D (2013) ATXN2 CAG repeat expansions increase the risk for Chinese patients with amyotrophic lateral sclerosis. Neurobiol Aging 34(9):2236 e2235–2236 e2238. doi:10.1016/j.neurobiolaging.2013.04.009
30. Lu CS, Wu Chou YH, Kuo PC, Chang HC, Weng YH (2004) The Parkinsonian phenotype of spinocerebellar ataxia type 2. Arch Neurol 61(1):35–38. doi:10.1001/archneur.61.1.35
31. Lu CS, Wu Chou YH, Yen TC, Tsai CH, Chen RS, Chang HC (2002) Dopa-responsive Parkinsonism phenotype of spinocerebellar ataxia type 2. Mov Disord 17(5):1046–1051. doi:10.1002/mds.10243
32. Mackenzie IR, Neumann M, Baborie A, Sampathu DM, Du Plessis D, Jaros E, Perry RH, Trojanowski JQ, Mann DM, Lee VM (2011) A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol 122(1):111–113. doi:10.1007/s00401-011-0845-8
33. Nanetti L, Fancellu R, Tomasello C, Gellera C, Pareyson D, Mariotti C (2009) Rare association of motor neuron disease and spinocerebellar ataxia type 2 (SCA2): a new case and review of the literature. J Neurol 256(11):1926–1928. doi:10.1007/s00415-009-5237-9
34. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, McCluskey LF, Miller BL, Masliah E, Mackenzie IR, Feldman H, Feiden W, Kretzschmar HA, Trojanowski JQ, Lee VM (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314(5796):130–133
35. Nihei Y, Ito D, Suzuki N (2012) Roles of ataxin-2 in pathological cascades mediated by TAR DNA-binding protein 43 (TDP-43) and fused in sarcoma (FUS). J Biol Chem 287(49):41310. doi:10.1074/jbc.M112.398099
36. Orsi L, D’Agata F, Caroppo P, Franco A, Caglio MM, Avidano F, Manzone C, Mortara P (2011) Neuropsychological picture of 33 spinocerebellar ataxia cases. J Clin Exp Neuropsychol 33(3):315–325. doi:10.1080/13803395.2010.518139
37. Pang JT, Giunti P, Chamberlain S, An SF, Vitaliani R, Scaravilli T, Martinian L, Wood NW, Scaravilli F, Ansorge O (2002) Neuronal intranuclear inclusions in SCA2: a genetic, morphological and immunohistochemical study of two cases. Brain 125(Pt 3):656–663
38. Proukakis C, Houlden H, Schapira AH (2013) Somatic alpha-synuclein mutations in Parkinson’s disease: hypothesis and preliminary data. Mov Disord 28(6):705–712. doi:10.1002/mds.25502
39. Pulst SM, Nechiporuk A, Nechiporuk T, Gispert S, Chen XN, Lopes-Cendes I, Pearlman S, Starkman S, Orozco-Diaz G, Lunkes A, DeJong P, Rouleau GA, Auburger G, Korenberg JR, Figueroa C, Sahba S (1996) Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nat Genet 14(3):269–276. doi:10.1038/ng1196-269
40. Pulst SM, Santos N, Wang D, Yang H, Huynh D, Velazquez L, Figueroa KP (2005) Spinocerebellar ataxia type 2: polyQ repeat variation in the CACNA1A calcium channel modifies age of onset. Brain 128(Pt 10):2297–2303. doi:10.1093/brain/awh586
41. Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, Schymick JC, Laaksovirta H, van Swieten JC, Myllykangas L, Kalimo H, Paetau A, Abramzon Y, Remes AM, Kaganovich A, Scholz SW, Duckworth J, Ding J, Harmer DW, Hernandez DG, Johnson JO, Mok K, Ryten M, Trabzuni D, Guerreiro RJ, Orrell RW, Neal J, Murray A, Pearson J, Jansen IE, Sondervan D, Seelaar H, Blake D, Young K, Halliwell N, Callister JB, Toulson G, Richardson A, Gerhard A, Snowden J, Mann D, Neary D, Nalls MA, Peuralinna T, Jansson L, Isoviita VM, Kaivorinne AL, Holtta-Vuori M, Ikonen E, Sulkava R, Benatar M, Wuu J, Chio A, Restagno G, Borghero G, Sabatelli M, Consortium I, Heckerman D, Rogaeva E, Zinman L, Rothstein JD, Sendtner M, Drepper C, Eichler EE, Alkan C, Abdullaev Z, Pack SD, Dutra A, Pak E, Hardy J, Singleton A, Williams NM, Heutink P, Pickering-Brown S, Morris HR, Tienari PJ, Traynor BJ (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72(2):257–268. doi:10.1016/j.neuron.2011.09.010
42. Reynaldo-Arminan RD, Reynaldo-Hernandez R, Paneque-Herrera M, Prieto-Avila L, Perez-Ruiz E (2002) Mental disorders in patients with spinocerebellar ataxia type 2 in Cuba. Rev Neurol 35(9):818–821
43. Ross OA, Rutherford NJ, Baker M, Soto-Ortolaza AI, Carrasquillo MM, DeJesus-Hernandez M, Adamson J, Li M, Volkening K, Finger E, Seeley WW, Hatanpaa KJ, Lomen-Hoerth C, Kertesz A, Bigio EH, Lippa C, Woodruff BK, Knopman DS, White CL 3rd, Van Gerpen JA, Meschia JF, Mackenzie IR, Boylan K, Boeve BF, Miller BL, Strong MJ, Uitti RJ, Younkin SG, Graff-Radford NR, Petersen RC, Wszolek ZK, Dickson DW, Rademakers R (2011) Ataxin-2 repeat-length variation and neurodegeneration. Hum Mol Genet 20(16):3207. doi:10.1093/hmg/ddr227
44. Rub U, Seidel K, Ozerden I, Gierga K, Brunt ER, Schols L, de Vos RA, den Dunnen W, Schultz C, Auburger G, Deller T (2007) Consistent affection of the central somatosensory system in spinocerebellar ataxia type 2 and type 3 and its significance for clinical symptoms and rehabilitative therapy. Brain Res Rev 53(2):235–249. doi:10.1016/j.brainresrev.2006.08.003
45. Sanpei K, Takano H, Igarashi S, Sato T, Oyake M, Sasaki H, Wakisaka A, Tashiro K, Ishida Y, Ikeuchi T, Koide R, Saito M, Sato A, Tanaka T, Hanyu S, Takiyama Y, Nishizawa M, Shimizu N, Nomura Y, Segawa M, Iwabuchi K, Eguchi I, Tanaka H, Takahashi H, Tsuji S (1996) Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT. Nat Genet 14(3):277–284. doi:10.1038/ng1196-277
46. Shan DE, Soong BW, Sun CM, Lee SJ, Liao KK, Liu RS (2001) Spinocerebellar ataxia type 2 presenting as familial levodopa-responsive Parkinsonism. Ann Neurol 50(6):812–815
47. Sobczak K, Krzyzosiak WJ (2005) CAG repeats containing CAA interruptions form branched hairpin structures in spinocerebellar ataxia type 2 transcripts. J Biol Chem 280(5):3898–3910. doi:10.1074/jbc.M409984200
48. Storey E, Forrest SM, Shaw JH, Mitchell P, Gardner RJ (1999) Spinocerebellar ataxia type 2: clinical features of a pedigree displaying prominent frontal-executive dysfunction. Arch Neurol 56(1):43–50
49. Takao M, Aoyama M, Ishikawa K, Sakiyama Y, Yomono H, Saito Y, Kurisaki H, Mihara B, Murayama S (2011) Spinocerebellar ataxia type 2 is associated with Parkinsonism and Lewy body pathology. BMJ Case Rep. doi:10.1136/bcr.01.2011.3685
50. Tazen S, Figueroa K, Kwan JY, Goldman J, Hunt A, Sampson J, Gutmann L, Pulst SM, Mitsumoto H, Kuo SH (2013) Amyotrophic lateral sclerosis and spinocerebellar ataxia type 2 in a family with full CAG repeat expansions of ATXN2. JAMA Neurol. doi:10.1001/jamaneurol.2013.443
51. Toyoshima Y, Tanaka H, Shimohata M, Kimura K, Morita T, Kakita A, Takahashi H (2011) Spinocerebellar ataxia type 2 (SCA2) is associated with TDP-43 pathology. Acta Neuropathol 122(3):375–378. doi:10.1007/s00401-011-0862-7
52. Van Damme P, Veldink JH, van Blitterswijk M, Corveleyn A, van Vught PW, Thijs V, Dubois B, Matthijs G, van den Berg LH, Robberecht W (2011) Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2. Neurology 76(24):2066–2072. doi:10.1212/WNL.0b013e31821f445b
53. Van Langenhove T, van der Zee J, Engelborghs S, Vandenberghe R, Santens P, Van den Broeck M, Mattheijssens M, Peeters K, Nuytten D, Cras P, De Deyn PP, De Jonghe P, Cruts M, Van Broeckhoven C (2012) Ataxin-2 polyQ expansions in FTLD-ALS spectrum disorders in Flanders-Belgian cohorts. Neurobiol Aging 33(5):1004 e1017–1004 e1020. doi:10.1016/j.neurobiolaging.2011.09.025
54. Wojciechowska M, Krzyzosiak WJ (2011) CAG repeat RNA as an auxiliary toxic agent in polyglutamine disorders. RNA Biol 8(4):565–571. doi:10.4161/rna.8.4.15397
55. Zu T, Gibbens B, Doty NS, Gomes-Pereira M, Huguet A, Stone MD, Margolis J, Peterson M, Markowski TW, Ingram MA, Nan Z, Forster C, Low WC, Schoser B, Somia NV, Clark HB, Schmechel S, Bitterman PB, Gourdon G, Swanson MS, Moseley M, Ranum LP (2011) Non-ATG-initiated translation directed by microsatellite expansions. Proc Natl Acad Sci USA 108(1):260–265. doi:10.1073/pnas.1013343108